Ann Hanley
Neurology · Cortlandt Manor, NYNPI 1700961497
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 173 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 10.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,564 and has fallen 98.5% since, to $38 in 2021.
Across 173 payments — averaging $15.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$274
- Sanofi$234
- Supernus Pharmaceuticals, Inc.$230
- Biogen$221
- Acadia Pharmaceuticals Inc$186
- Genentech USA, Inc.$131
- plus $1K from 25 others
What the payments were for
- Speaking & faculty fees$311%
- Food & beverage$2,53496%
- Education$673%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 19 | $274 |
| Sanofi | 11 | $234 |
| Supernus Pharmaceuticals, Inc. | 20 | $230 |
| Biogen | 13 | $221 |
| Acadia Pharmaceuticals Inc | 19 | $186 |
| Genentech USA, Inc. | 6 | $131 |
| Arbor Pharmaceuticals, Inc. | 7 | $103 |
| MDD US Operations, LLC | 6 | $95 |
| EMD Serono, Inc. | 6 | $88 |
| AstraZeneca | 5 | $87 |
| UCB, Inc. | 5 | $83 |
| Assertio Therapeutics, Inc. | 5 | $80 |
| Sunovion Pharmaceuticals Inc. | 5 | $78 |
| Vertical Pharmaceuticals, LLC | 4 | $72 |
| Lilly USA, LLC | 5 | $72 |
| Amneal Pharmaceuticals LLC | 5 | $71 |
| Lundbeck LLC | 4 | $61 |
| Indivior Inc. | 3 | $61 |
| Grifols USA, LLC | 4 | $59 |
| Teva Pharmaceuticals USA, Inc. | 4 | $53 |
| Akcea Therapeutics, Inc. | 3 | $51 |
| Avanir Pharmaceuticals, Inc. | 2 | $43 |
| Eisai Inc. | 2 | $38 |
| Acorda Therapeutics, Inc | 2 | $31 |
| CSL Behring | 2 | $31 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Catalyst Pharmaceuticals, Inc. | 1 | $18 |
| Medtronic | 1 | $17 |
| Kyowa Kirin, Inc. | 1 | $17 |
| Bausch Health US, LLC | 1 | $14 |
| Portola Pharmaceuticals, LLC | 1 | $12 |
How this compares
$2,632 in reported general payments places this provider in the 60th percentile of 1,623 neurology providers in New York.
Other neurology in Cortlandt Manor
- Idan SharonBrooklyn$2.1M
- Allan PerelStaten Island$1.7M
- Nicolas SaikaliAmherst$1.5M
- David KreitzmanCommack$1.5M
- Charles ArgoffAlbany$1.2M
- Stephen KriegerNew York$1.1M
- Robert FeketeHawthorne$1M
- Jennifer McVigeAmherst$982K
- Warren SpinnerPort Jefferson Station$791K
- Richard LiptonBronx$753K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.